ArriVent BioPharma, Inc. (AVBP)

Typically moves ±3.67% on earnings

EARNINGS ANALYTICS

notifications_active EARNINGS TODAY (2026-08-12)

Across 10 earnings reports since Mar 28, 2024, ArriVent BioPharma, Inc. (AVBP) has a clear post-earnings pattern. It moves ±3.67% on average after reporting and finishes higher 30.0% of the time. Its largest post-earnings gain was +3.08% (Nov 10, 2025) and its largest decline was -11.86% (Nov 14, 2024). The next earnings report is predicted for 2026-08-12 (today).

Earnings reactions

How AVBP moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.67%

Positive %

30.0%

Negative %

70.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 11, 2026	☽ POST	-0.21%	open_in_new
Mar 05, 2026	☽ POST	-7.21%	open_in_new
Nov 10, 2025	☀ PRE	+3.08%	open_in_new
Aug 11, 2025	☀ PRE	-3.34%	open_in_new
May 12, 2025	☀ PRE	-0.79%	open_in_new
Mar 03, 2025	☀ PRE	-6.69%	open_in_new
Nov 14, 2024	☀ PRE	-11.86%	open_in_new
Aug 14, 2024	☽ POST	-0.38%	open_in_new
May 08, 2024	☀ PRE	+0.64%	open_in_new
Mar 28, 2024	☽ POST	+2.52%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.67%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 14 →

Funds holding

$131184979

Total value held

Buying

12 added · 2 reduced

Blackrock, Inc.

$58374044 +6.64%

State Street Corp

$32792044 +30.17%

Goldman Sachs Group Inc

$19688560 +14.94%

Northern Trust Corp

$6201493 +9.45%

Nomura Holdings Inc

$5584094 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

description SCHEDULE 13G

6 chevron_right

description UPLOAD

4 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260727	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov
SCHEDULE 13G/A	20260506	open_in_new SEC.gov
ARS	20260428	open_in_new SEC.gov
DEFA14A	20260428	open_in_new SEC.gov
DEF 14A	20260428	open_in_new SEC.gov

Frequently asked about AVBP earnings

When does ArriVent BioPharma, Inc. report earnings next? expand_more

ArriVent BioPharma, Inc. (AVBP)'s next earnings date is predicted for today for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does AVBP stock move after earnings? expand_more

Over 10 reports, AVBP has moved an average of ±3.67% the session after earnings, closing higher 30.0% of the time.

What was AVBP's biggest post-earnings move? expand_more

AVBP's largest post-earnings gain on record was +3.08% on Nov 10, 2025, and its largest decline was -11.86% on Nov 14, 2024.

Where can I find ArriVent BioPharma, Inc.'s SEC filings? expand_more

All of ArriVent BioPharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.